Literature DB >> 22339190

HIV and malaria interactions: where do we stand?

Raquel González1, Ricardo Ataíde, Denise Naniche, Clara Menéndez, Alfredo Mayor.   

Abstract

Reversing the spread of HIV infection and the incidence of malaria constitute two of the Millenium Development Goals. However, despite recent achievements, both diseases still entail global heath problems. Furthermore, their overlapping geographical distribution raises concerns and challenges for potential immunological, clinical and therapeutic interactions. It has been reported that HIV infection increases malaria susceptibility and reduces the efficacy of antimalarial drugs. On the other hand, the effect of malaria on HIV-infected individuals has also been explored, with the parasitic infection increasing the risk of HIV disease progression and mother-to-child transmission of HIV. The spread of malaria and parasite resistance to antimalarials could also be accelerated by HIV-associated immunosuppresion. Current knowledge of the epidemiological, clinical, immunological and therapeutic interactions of the two diseases is reviewed in this article. We focus on the latest available data, pointing out key future research areas and challenges of the field.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339190     DOI: 10.1586/eri.11.167

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  34 in total

1.  Rapid HIV progression during acute HIV-1 subtype C infection in a Mozambican patient with atypical seroconversion.

Authors:  Cesar Velasco; Erica Parker; Lucia Pastor; Abel Nhama; Salesio Macuacua; Inácio Mandomando; Julià Blanco; Denise Naniche
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

2.  Dengue Infection in a Human Immunodeficiency Virus-1 Positive Patient Chronically Infected with Hepatitis B Virus in Western Mexico.

Authors:  Iván Delgado-Enciso; Francisco Espinoza-Gómez; Rodolfo Ochoa-Jiménez; Salvador Valle-Reyes; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

Review 3.  The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.

Authors:  Ruthie B Birger; Roger D Kouyos; C Jessica E Metcalf; Ted Cohen; Emily C Griffiths; Silvie Huijben; Michael J Mina; Victoriya Volkova; Bryan Grenfell
Journal:  Trends Microbiol       Date:  2015-05-29       Impact factor: 17.079

4.  Dengue Virus Coinfection in Human Immunodeficiency Virus-1-Infected Patients on the West Coast of Mexico.

Authors:  Francisco Espinoza-Gómez; Iván Delgado-Enciso; Salvador Valle-Reyes; Rodolfo Ochoa-Jiménez; Conrado Arechiga-Ramírez; José L Gámez-Arroyo; Roberto Vázquez-Campuzano; Carmen Guzmán-Bracho; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

5.  Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana.

Authors:  Leabaneng Tawe; Michela Menegon; Pleasure Ramatlho; Charles W Muthoga; Naledi Mutukwa; Moses Vurayai; Wame Bothudile; Thato Motshoge; Mariangela L'Episcopia; Tjantilili Mosweunyane; Ishmael Kasvosve; Carlo Severini; Giacomo M Paganotti
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

6.  HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults.

Authors:  Krishanthi S Subramaniam; Jeff Skinner; Emil Ivan; Eugene Mutimura; Ryung S Kim; Catherine M Feintuch; Silvia Portugal; Kathryn Anastos; Peter D Crompton; Johanna P Daily
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

7.  Maternal mortality in Malawi, 1977-2012.

Authors:  Tim Colbourn; Sonia Lewycka; Bejoy Nambiar; Iqbal Anwar; Ann Phoya; Chisale Mhango
Journal:  BMJ Open       Date:  2013-12-18       Impact factor: 2.692

8.  Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.

Authors:  Calvin Tonga; Helen Kuokuo Kimbi; Judith Kuoh Anchang-Kimbi; Hervé Nyabeyeu Nyabeyeu; Zacharie Bissemou Bissemou; Léopold G Lehman
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

Review 9.  Mefloquine safety and tolerability in pregnancy: a systematic literature review.

Authors:  Raquel González; Urban Hellgren; Brian Greenwood; Clara Menéndez
Journal:  Malar J       Date:  2014-02-28       Impact factor: 2.979

Review 10.  HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Authors:  Charles R Rinaldo
Journal:  Scientifica (Cairo)       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.